I can't answer the question of the actual date for the OTAT meeting but I think the fact that MSB have spent US$10m getting their ducks in a row for this meeting is an indication of the effort they have expended to prepare for it - hopefully that is enough for a positive outcome.
I'm sure there are a number of other cell therapy players out there watching this meeting with interest as if US$10m worth of investment in potency assays and CQA analysis can't get you over the line with the FDA then the whole industry is going to lose investment.
MSB Trading 2021 - paradigm shift, page-7761
-
- There are more pages in this discussion • 2,450 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |